Schorno Dean L
CIK 1509688
Transactions on file
11
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-09-03 | 2026-09-02 | RIGL RIGEL PHARMACEUTICALS INC | EVP & Chief Financial Officer | Exer. | 1,286 | $31.1K | +94.8% | open → |
| 2026-09-03 | 2026-09-02 | RIGL RIGEL PHARMACEUTICALS INC | EVP & Chief Financial Officer | Exer. | 2,000 | $48.4K | +94.8% | open → |
| 2026-09-03 | 2026-09-02 | RIGL RIGEL PHARMACEUTICALS INC | EVP & Chief Financial Officer | Exer. | 620 | $11.6K | +152.1% | open → |
| 2026-09-03 | 2026-09-02 | RIGL RIGEL PHARMACEUTICALS INC | EVP & Chief Financial Officer | Exer. | 694 | $8.8K | +271.3% | open → |
| 2026-09-03 | 2026-09-01 | RIGL RIGEL PHARMACEUTICALS INC | EVP & Chief Financial Officer | Tax | 928 | $44.1K | -0.7% | open → |
| 2026-06-03 | 2026-06-01 | RIGL RIGEL PHARMACEUTICALS INC | EVP & Chief Financial Officer | Tax | 928 | $27.7K | +57.9% | open → |
| 2026-06-03 | 2026-06-01 | RIGL RIGEL PHARMACEUTICALS INC | EVP & Chief Financial Officer | Exer. | 2,181 | $27.7K | +271.3% | open → |
| 2026-06-03 | 2026-06-01 | RIGL RIGEL PHARMACEUTICALS INC | EVP & Chief Financial Officer | Exer. | 1,200 | $22.4K | +152.1% | open → |
| 2025-01-31 | 2025-01-29 | RIGL RIGEL PHARMACEUTICALS INC | Officer EVP & Chief Financial Officer | Grant | 19,717 | $0.00 | — | open → |
| 2025-02-06 | 2025-02-05 | RIGL RIGEL PHARMACEUTICALS INC | Officer EVP & Chief Financial Officer | Sale | 1,734 | $38.0K | +115.0% | open → |
| 2025-02-06 | 2025-02-04 | RIGL RIGEL PHARMACEUTICALS INC | Officer EVP & Chief Financial Officer | Sale | 2,036 | $42.6K | +125.4% | open → |
